Skip to content

Clinical trials

Phase 2 Ischemic Stroke trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 2 Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20041
20051
20061
20092
20102
20111
20124
20132
20141
20162
20192
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status6
Terminated5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital Heidelberg5
Astellas Pharma Inc2
Biogen2
PAION Deutschland GmbH2
Bayer1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
Daiichi Sankyo1
GlaxoSmithKline1
Heidelberg University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke27
Stroke16
Hypothermia5
Hemorrhagic Stroke4
Cerebrovascular Disorders3
Intracranial Hemorrhages3
Aphasia1
Central Nervous System Diseases1
Cerebral Hemorrhage1
Cerebral Infarction1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.